Restoring Immune Homeostasis In Long COVID

Amy E. Clarke, DNP, RN, IgCN®Chief Clinical OfficerImmunoglobulin National SocietyCalabasas, CaliforniaLuba Sobolevsky, PharmD, IgCP®President and CEOImmunoglobulin National SocietyCalabasas, CaliforniaPost-acute sequelae of SARS-CoV-2 infection (PASC, commonly referred to as long COVID) has emerged as a chronic multisystem consequence of the COVID-19 pandemic, representing a growing clinical and societal burden. It affects an estimated 1 in 3 survivors worldwide, with symptoms in 36% of